Metropolitan Life Insurance Company (MetLife)’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,949
| Closed | -$1.36M | – | 2606 |
|
|
2020
Q3 | $1.36M | Sell |
15,949
-413
| -3% | -$20.9K | 0.02% | 589 |
|
|
2020
Q2 | $580K | Sell |
16,362
-41,246
| -72% | -$1.21M | 0.01% | 1090 |
|
|
2020
Q1 | $777K | Buy |
57,608
+2,249
| +4% | +$37.8K | 0.02% | 808 |
|
|
2019
Q4 | $1.17M | Sell |
55,359
-1,693
| -3% | -$29.9K | 0.02% | 802 |
|
|
2019
Q3 | $757K | Buy |
57,052
+7,313
| +15% | +$107K | 0.01% | 1027 |
|
|
2019
Q2 | $690K | Buy |
49,739
+1,629
| +3% | +$24.5K | 0.01% | 1107 |
|
|
2019
Q1 | $924K | Buy |
48,110
+1,757
| +4% | +$28.3K | 0.02% | 925 |
|
|
2018
Q4 | $661K | Buy |
46,353
+847
| +2% | +$16.8K | 0.01% | 1039 |
|
|
2018
Q3 | $948K | Sell |
45,506
-12,057
| -21% | -$286K | 0.02% | 970 |
|
|
2018
Q2 | $1.36M | Buy |
57,563
+26,471
| +85% | +$532K | 0.02% | 766 |
|
|
2018
Q1 | $454K | Sell |
31,092
-3,129
| -9% | -$51.1K | 0.01% | 1344 |
|
|
2017
Q4 | $553K | Sell |
34,221
-37,331
| -52% | -$441K | 0.01% | 1222 |
|
|
2017
Q3 | $1M | Sell |
71,552
-1,258
| -2% | -$12.5K | 0.01% | 1251 |
|
|
2017
Q2 | $643K | Hold |
72,810
| – | – | ﹤0.01% | 1511 |
|
|
2017
Q1 | $471K | Buy |
72,810
+6,761
| +10% | +$34.3K | ﹤0.01% | 1689 |
|
|
2016
Q4 | $242K | Buy |
66,049
+2,384
| +4% | +$7.05K | ﹤0.01% | 2236 |
|
|
2016
Q3 | $207K | Sell |
63,665
-10,793
| -14% | -$30.2K | ﹤0.01% | 2317 |
|
|
2016
Q2 | $173K | Hold |
74,458
| – | – | ﹤0.01% | 2423 |
|
|
2016
Q1 | $186K | Hold |
74,458
| – | – | ﹤0.01% | 2223 |
|
|
2015
Q4 | $229K | Sell |
74,458
-475
| -0.6% | -$1.33K | ﹤0.01% | 2161 |
|
|
2015
Q3 | $129K | Buy |
74,933
+18,491
| +33% | +$47.2K | ﹤0.01% | 2535 |
|
|
2015
Q2 | $229K | Sell |
56,442
-5,231
| -8% | -$21.4K | ﹤0.01% | 2311 |
|
|
2015
Q1 | $236K | Buy |
61,673
+284
| +0.5% | +$1.24K | ﹤0.01% | 1982 |
|
|
2014
Q4 | $295K | Hold |
61,389
| – | – | ﹤0.01% | 2142 |
|
|
2014
Q3 | $228K | Hold |
61,389
| – | – | ﹤0.01% | 2277 |
|
|
2014
Q2 | $224K | Hold |
61,389
| – | – | ﹤0.01% | 2437 |
|
|
2014
Q1 | $258K | Hold |
61,389
| – | – | ﹤0.01% | 2283 |
|
|
2013
Q4 | $282K | Hold |
61,389
| – | – | ﹤0.01% | 2224 |
|
|
2013
Q3 | $380K | Hold |
61,389
| – | – | ﹤0.01% | 1949 |
|
|
2013
Q2 | $334K | Buy |
+61,389
| New | +$202K | ﹤0.01% | 1974 |
|
Metropolitan Life Insurance Company (MetLife)'s IMMU Position: Q4 2020 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 15,949 shares — an estimated $1.36M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $1.36M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 15,949 Immunomedics Inc shares in Q4 2020, an estimated $1.36M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Immunomedics Inc position peaked at $1.36M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.